• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

OPKO Health (OPK)

Common Shares
Sell: $1.47|Buy: $1.50|Change: 0.03 (2.03%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Address

4400 Biscayne Boulevard
Miami
FL
USA
33137

Telephone

+1 305 5754100

Website

https://www.opko.com

Sector 

Healthcare

Forecast key dates

NameKey Date
OPKO Health Inc Second Quarter Earnings Conference Call for 20262026-07-31T16:30:00
OPKO Health Inc Second Quarter Earnings Results for 20262026-07-31T00:00:00
OPKO Health Inc First Quarter Earnings Conference Call for 20262026-04-30T16:30:00
OPKO Health Inc First Quarter Earnings Results for 20262026-04-30T00:00:00
OPKO Health Inc Annual General Meeting for 20262026-04-23T10:00:00
OPKO Health Inc Annual Report for 20252026-03-03T00:00:00
OPKO Health Inc Fourth Quarter Earnings Conference Call for 20252026-02-27T16:30:00
OPKO Health Inc Fourth Quarter Earnings Results for 20252026-02-27T00:00:00
OPKO Health Inc Third Quarter Earnings Conference Call for 20252025-11-07T16:30:00
OPKO Health Inc Third Quarter Earnings Results for 20252025-11-07T00:00:00

Previous key dates

NameKey Date
OPKO Health Inc Second Quarter Earnings Conference Call for 20252025-07-31T16:30:00
OPKO Health Inc Second Quarter Earnings Result for 20252025-07-31T00:00:00
Jefferies Global Healthcare Conference2025-06-04T11:05:00
H.C. Wainwright 3rd Annual BioConnect Investor Conference2025-05-20T09:00:00
OPKO Health Inc First Quarter Earnings Conference Call for 20252025-04-30T16:30:00
OPKO Health Inc First Quarter Earnings Results for 20252025-04-30T00:00:00
OPKO Health Inc Annual General Meeting for 20252025-04-23T10:00:00
OPKO Health Inc Annual Report for 20242025-03-03T00:00:00
OPKO Health Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T16:30:00
OPKO Health Inc Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-15T15:00:00
Piper Sandler 36th Annual Healthcare Conference2024-12-04T13:30:00
OPKO Health Inc Third Quarter Earnings Conference Call for 20242024-11-07T16:30:00
OPKO Health Inc Third Quarter Earnings Result for 20242024-11-07T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.